0001661181-21-000011.txt : 20210216
0001661181-21-000011.hdr.sgml : 20210216
20210216201511
ACCESSION NUMBER: 0001661181-21-000011
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210211
FILED AS OF DATE: 20210216
DATE AS OF CHANGE: 20210216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NUSSDORF GLENN H
CENTRAL INDEX KEY: 0001244191
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37906
FILM NUMBER: 21642092
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wisdom Starr
CENTRAL INDEX KEY: 0001760694
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37906
FILM NUMBER: 21642093
MAIL ADDRESS:
STREET 1: C/O ORGANOGENESIS INC.
STREET 2: 85 DAN ROAD
CITY: CANTON
STATE: MA
ZIP: 02021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Organogenesis Holdings Inc.
CENTRAL INDEX KEY: 0001661181
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 DAN ROAD
CITY: CANTON
STATE: MA
ZIP: 02021
BUSINESS PHONE: 781-575-0775
MAIL ADDRESS:
STREET 1: 85 DAN ROAD
CITY: CANTON
STATE: MA
ZIP: 02021
FORMER COMPANY:
FORMER CONFORMED NAME: Avista Healthcare Public Acquisition Corp.
DATE OF NAME CHANGE: 20151215
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-02-11
0001661181
Organogenesis Holdings Inc.
ORGO
0001244191
NUSSDORF GLENN H
35 SAWGRASS DRIVE
BELLPORT
NY
11713
1
0
1
0
0001760694
Wisdom Starr
44 WILSON STREET
HARTSDALE
NY
10530
0
0
1
0
Class A Common Stock
2021-02-11
4
S
0
200000.0
3.25
D
68594976.0
D
The reported securities sold were held directly by Alan A. Ades, who is a member of the Group (as defined below). On November 17, 2020, Mr. Ades purchased shares of Class A common stock of Organogenesis Holdings Inc. at a price of $3.25 per share, including (i) 100,000 shares purchased by Mr. Ades as agent for and for the benefit of one of his sons and (ii) 100,000 shares purchased by Mr. Ades as agent for and for the benefit of an entity that is managed by Mr. Ades' son-in-law. This Form 4 reflects the sales of such shares.
Alan A. Ades, Albert Erani, Glenn H. Nussdorf, Dennis Erani, Starr Wisdom and certain of their respective affiliates, including Organo PFG LLC, Organo Investors LLC, Dennis Erani 2012 Issue Trust, Alan Ades as Trustee of the Alan Ades 2014 GRAT, Albert Erani Family Trust dated 12/29/2012, GN 2016 Family Trust u/a/d August 12, 2016 and GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016, referred to collectively as the "Controlling Entities", are parties to a Controlling Stockholders' Agreement dated December 10, 2018 with Organogenesis Holdings Inc. (the "Stockholders' Agreement"). The Stockholders' Agreement, among other things, provides for nomination rights of the Controlling Entities with respect to four directors of the Issuer and qualifies the Issuer as a "controlled company" under the Nasdaq listing rules. As a result of the Stockholders' Agreement, the reporting persons may be deemed to be members of a group (the "Group") holding over 10% of the outstanding shares of common stock of the issuer for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended.
This is Form 4 No. 2 of 2 filed for the Controlling Entities.
/s/ Stacie S. Aarestad, Attorney-in-Fact
2021-02-16